Tyme Technologies (TYME) Trading Up 11.1%

Tyme Technologies Inc (NASDAQ:TYME)’s share price was up 11.1% during trading on Monday . The stock traded as high as $3.11 and last traded at $3.11. Approximately 612,702 shares were traded during trading, a decline of 50% from the average daily volume of 1,216,479 shares. The stock had previously closed at $2.80.

Several equities analysts have commented on TYME shares. HC Wainwright reissued a “buy” rating and set a $10.00 target price on shares of Tyme Technologies in a research report on Wednesday, November 7th. Zacks Investment Research cut shares of Tyme Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, January 10th. Finally, BidaskClub raised shares of Tyme Technologies from a “sell” rating to a “hold” rating in a research report on Wednesday, December 5th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. Tyme Technologies presently has a consensus rating of “Hold” and an average target price of $7.58.

The stock has a market capitalization of $288.93 million, a P/E ratio of -14.81 and a beta of 0.32.

Several institutional investors have recently bought and sold shares of TYME. Bank of New York Mellon Corp purchased a new stake in shares of Tyme Technologies during the 2nd quarter worth approximately $267,000. Schwab Charles Investment Management Inc. purchased a new position in shares of Tyme Technologies during the second quarter valued at about $248,000. BlackRock Inc. purchased a new position in shares of Tyme Technologies during the second quarter valued at about $6,303,000. Northern Trust Corp purchased a new stake in Tyme Technologies in the second quarter worth about $1,181,000. Finally, Wells Fargo & Company MN grew its holdings in Tyme Technologies by 149.1% in the third quarter. Wells Fargo & Company MN now owns 266,026 shares of the company’s stock worth $739,000 after purchasing an additional 159,251 shares during the period. 11.39% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This news story was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.com-unik.info/2019/02/11/tyme-technologies-tyme-trading-up-11-1.html.

Tyme Technologies Company Profile (NASDAQ:TYME)

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Recommended Story: Trading signals using Bollinger bands

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit